699 related articles for article (PubMed ID: 9884835)
41. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group.
Brandt ME; Pfaller MA; Hajjeh RA; Graviss EA; Rees J; Spitzer ED; Pinner RW; Mayer LW
J Infect Dis; 1996 Oct; 174(4):812-20. PubMed ID: 8843221
[TBL] [Abstract][Full Text] [Related]
42. Correlation of fluconazole MICs with clinical outcome in cryptococcal infection.
Aller AI; Martin-Mazuelos E; Lozano F; Gomez-Mateos J; Steele-Moore L; Holloway WJ; Gutiérrez MJ; Recio FJ; Espinel-Ingroff A
Antimicrob Agents Chemother; 2000 Jun; 44(6):1544-8. PubMed ID: 10817706
[TBL] [Abstract][Full Text] [Related]
43. A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.
Chau TT; Mai NH; Phu NH; Nghia HD; Chuong LV; Sinh DX; Duong VA; Diep PT; Campbell JI; Baker S; Hien TT; Lalloo DG; Farrar JJ; Day JN
BMC Infect Dis; 2010 Jul; 10():199. PubMed ID: 20618932
[TBL] [Abstract][Full Text] [Related]
44. Cryptococcus neoformans var neoformans resistant to fluconazole in an HIV-negative patient with chronic lymphocytic leukemia.
Assing K; Birgens H; Arendrup M
Clin Microbiol Infect; 2003 May; 9(5):441-4. PubMed ID: 12848761
[TBL] [Abstract][Full Text] [Related]
45. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Doern GV; Diekema DJ
J Clin Microbiol; 2005 May; 43(5):2163-7. PubMed ID: 15872236
[TBL] [Abstract][Full Text] [Related]
46. Genotypic diversity in clinical and environmental isolates of Cryptococcus neoformans from India using multilocus microsatellite and multilocus sequence typing.
Prakash A; Sundar G; Sharma B; Hagen F; Meis JF; Chowdhary A
Mycoses; 2020 Mar; 63(3):284-293. PubMed ID: 31820495
[TBL] [Abstract][Full Text] [Related]
47. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.
Casadevall A; Spitzer ED; Webb D; Rinaldi MG
Antimicrob Agents Chemother; 1993 Jun; 37(6):1383-6. PubMed ID: 8328793
[TBL] [Abstract][Full Text] [Related]
48. Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformans.
Mahabeer Y; Chang CC; Naidu D; Dorasamy A; Lewin S; Ndung'u T; Moosa MY; French M; Mlisana K; Coovadia Y
Diagn Microbiol Infect Dis; 2014 Dec; 80(4):294-8. PubMed ID: 25277745
[TBL] [Abstract][Full Text] [Related]
49. Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.
Kassi FK; Drakulovski P; Bellet V; Roger F; Chabrol A; Krasteva D; Doumbia A; Landman R; Kakou A; Reynes J; Delaporte E; Menan HEI; Bertout S
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007812. PubMed ID: 31738768
[TBL] [Abstract][Full Text] [Related]
50. G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate.
Rodero L; Mellado E; Rodriguez AC; Salve A; Guelfand L; Cahn P; Cuenca-Estrella M; Davel G; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2003 Nov; 47(11):3653-6. PubMed ID: 14576140
[TBL] [Abstract][Full Text] [Related]
51. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
Jaruratanasirikul S
Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
[TBL] [Abstract][Full Text] [Related]
52. Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis.
Wiesner DL; Moskalenko O; Corcoran JM; McDonald T; Rolfes MA; Meya DB; Kajumbula H; Kambugu A; Bohjanen PR; Knight JF; Boulware DR; Nielsen K
mBio; 2012; 3(5):. PubMed ID: 23015735
[TBL] [Abstract][Full Text] [Related]
53. Reduced Susceptibility to Azoles in Cryptococcus gattii Correlates with the Substitution R258L in a Substrate Recognition Site of the Lanosterol 14-α-Demethylase.
Carvajal SK; Melendres J; Escandón P; Firacative C
Microbiol Spectr; 2023 Aug; 11(4):e0140323. PubMed ID: 37341584
[TBL] [Abstract][Full Text] [Related]
54. Antifungal Susceptibility Does Not Correlate With Fungal Clearance or Survival in AIDS-Associated Cryptococcal Meningitis.
O'Connor L; Van Anh D; Chau TTH; Chau NVV; Huong LNP; Wolbers M; Day JN
Clin Infect Dis; 2021 Oct; 73(7):e2338-e2341. PubMed ID: 33051650
[TBL] [Abstract][Full Text] [Related]
55. Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade.
Naicker SD; Mpembe RS; Maphanga TG; Zulu TG; Desanto D; Wadula J; Mvelase N; Maluleka C; Reddy K; Dawood H; Maloba M; Govender NP;
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008137. PubMed ID: 32231354
[TBL] [Abstract][Full Text] [Related]
56. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis.
Spitzer ED; Spitzer SG; Freundlich LF; Casadevall A
Lancet; 1993 Mar; 341(8845):595-6. PubMed ID: 8094831
[TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Perfect JR; Cox GM; Dodge RK; Schell WA
Antimicrob Agents Chemother; 1996 Aug; 40(8):1910-3. PubMed ID: 8843302
[TBL] [Abstract][Full Text] [Related]
58. Fluconazole-resistant Cryptococcus neoformans var gattii in an AIDS patient.
Peetermans W; Bobbaers H; Verhaegen J; Vandepitte J
Acta Clin Belg; 1993; 48(6):405-9. PubMed ID: 8128821
[TBL] [Abstract][Full Text] [Related]
59. Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.
de Carvalho Santana R; Schiave LA; Dos Santos Quaglio AS; de Gaitani CM; Martinez R
Mycopathologia; 2017 Oct; 182(9-10):855-861. PubMed ID: 28656554
[TBL] [Abstract][Full Text] [Related]
60. Fluconazole-resistant cryptococcal meningitis.
Momoff N; Parrish A
S Afr Med J; 2003 Jun; 93(6):444. PubMed ID: 12916384
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
